Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01610973
Other study ID # 2010/084/HP
Secondary ID 2011-A00221-40
Status Completed
Phase N/A
First received April 25, 2012
Last updated October 7, 2016
Start date June 2012
Est. completion date August 2016

Study information

Verified date October 2016
Source University Hospital, Rouen
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

The cornea is a transparent membrane, half a millimeter thick, embedded as a window in front of the eye.

When the eye becomes opaque, the eye is not seeing and the only way to restore the visual acuity is to replace the cornea by performing a graft (4000 surgeries per year in France). In half the cases the opacification of the cornea is secondary to dysfunction of the endothelium, cell layer of 15 μm thickness, covering its posterior surface, in charge of regulating the moisture of the corneal thickness and therefore its transparency.

While the total corneal transplantation has long been the only intervention for these diseases, it is now possible, from 4-5 years, to replace only the very thin: it is called endothelial transplant or graft lamellar later. This intervention is now experiencing significant success as it reduces very significantly the incidence of complications found after transplantation of total cornea and the visual recovery period. This type of transplant is still difficult to achieve and the best technique is not yet established.

Indeed, posterior lamellar transplantation of the cornea may be done manually or using an automated device. Manual techniques allow the preparation of grafts extremely thin but are difficult to achieve while the automatic techniques, easier, prepare thicker grafts that may be less efficient in visual recovery.

The aim of this project is to conduct a prospective study in order to compare these two techniques in terms of postoperative visual recovery and the vitality of the graft during the first year. To date, there is no such study.

The department of Ophthalmology in the University Hospital of Rouen is one of the most famous French teams in the field of cornea transplants and receives many patients from different French regions. The recruitment of 40 patients needed to study should be done without great difficulty over a period of 18 months.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- men and woman

- 18 years old or more

- Patient having been informed about the study and having signed a non-opposition to the participation

Exclusion Criteria:

- Patient presenting an associated eye pathology previously known and able to limit the visual recovery (age-related macular degeneration, diabetic retinopathy, ...)

- Pregnant women, parturient or breast feeding

- refusal to participate in the study

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Procedure:
Endothelial descemet membrane graft
Standard Endothelial descemet membrane graft
Endothelial descemet membrane graft
Standard Endothelial descemet membrane graft

Locations

Country Name City State
France UH Rouen Rouen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Rouen

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of visual acuity 1 year No
Secondary Occular hypertension Measurement of occular hypertension Day 7, Day 15, Month 1, Month 2, Month 6, 1 year Yes
Secondary Measurement of visual acuity Month 1, Month 2, Month 6 No
Secondary Partial or complete graft detachment % of detachment Day 7, Day 15, Month 1, Month 2, Month 6, 1 year Yes
Secondary Necessity of air injection Necessity of air injection : yes/no Day 7, Day 15, Month 1, Month 2, Month 6, 1 year Yes
Secondary Defeat of the graft Defeat of the graft : yes/no Day 7, Day 15, Month 1, Month 2, Month 6, 1 year Yes
See also
  Status Clinical Trial Phase
Recruiting NCT01791075 - Comparing Endoglide to Endoserter for DSAEK Graft Insertion N/A
Withdrawn NCT02109276 - Study of the Effect of Aspheric Lenses in Patients With Fuch's Dystrophy N/A
Not yet recruiting NCT00623584 - Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture Media N/A